Analyst Reco. Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-30 pm EDT			Pre-market 07:57:22 am
79.58 ^USD	+5.52%		76.94	-3.32%

Apr. 25	Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	MT
Apr. 24	Viking Therapeutics Q1 Loss Widens; Shares Fall After Hours	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oppenheimer Adjusts Viking Therapeutics Price Target to $138 From $116, Maintains Outperform Rating	Mar. 27	MT
Stifel Adjusts Viking Therapeutics Price Target to $95 From $80, Maintains Buy Rating	Mar. 26	MT
BTIG Raises Price Target on Viking Therapeutics to $100 From $86, Keeps Buy Rating	Mar. 15	MT
Jefferies Starts Viking Therapeutics With Buy Rating, $110 Price Target	Mar. 07	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $116 From $46, Maintains Outperform Rating	Feb. 28	MT
HC Wainwright Raises Price Target on Viking Therapeutics to $90 From $33, Keeps Buy Rating	Feb. 27	MT
Stifel Adjusts Price Target on Viking Therapeutics to $35 From $30, Maintains Buy Rating	Feb. 14	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $46 From $40, Maintains Outperform Rating	Feb. 08	MT
Health Care Down on Rotation to Rate-Sensitive Sectors -- Health Care Roundup	23-07-07	DJ
Raymond James Adjusts Viking Therapeutics Price Target to $37 From $35, Maintains Outperform Rating	23-05-17	MT
Stifel Adjusts Viking Therapeutics' Price Target to $30 From $25, Keeps Buy Rating	23-05-16	MT
BTIG Adjusts Viking Therapeutics' Price Target to $36 From $31, Keeps Buy Rating	23-05-16	MT
Roth MKM Adjusts Price Target on Viking Therapeutics to $24 From $19, Maintains Buy Rating	23-05-03	MT
HC Wainwright Adjusts Price Target on Viking Therapeutics to $33 From $21, Maintains Buy Rating	23-04-27	MT
Oppenheimer Adjusts Viking Therapeutics Price Target to $35 From $30, Maintains Outperform Rating	23-04-25	MT
BTIG Research Adjusts Viking Therapeutics Price Target to $31 From $20, Maintains Buy Rating	23-03-29	MT
Raymond James Adjusts Viking Therapeutics Price Target to $35 From $12, Maintains Outperform Rating	23-03-29	MT
Stifel Nicolaus Adjusts Viking Therapeutics Price Target to $25 From $22, Maintains Buy Rating	23-03-28	MT
Stifel Initiates Viking Therapeutics at Buy With $22 Price Target	23-03-17	MT
Raymond James Adjusts Price Target on Viking Therapeutics to $12 From $11, Maintains Outperform Rating	23-02-09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Viking Therapeutics, Inc.

Equities

VKTX

US92686J1060

Analyst Reco.

Filters